Although the underlying mechanisms of HNSCC remain to be explored, it is possible that G9a epigenetically directs the growth advantage for cancer cells by suppressing key regulators in apoptosis or the cell cycle through multiple routes. This evidence concerns the gene EHMT2 and cancer.